Proprietary AI analyst is now available

Panion & Bf Biotech Valuation Multiples

Discover revenue and EBITDA valuation multiples for Panion & Bf Biotech and similar public comparables like Precision BioSciences, Innate Pharma, ADC Therapeutics, Hyloris Pharmaceuticals and more.

Panion & Bf Biotech Overview

About Panion & Bf Biotech

Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company along with its subsidiaries is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan, China, Hong Kong, and Macau, the USA, and Korea. It generates a majority of its revenue from the Taiwan segment.


Founded

1976

HQ

Taiwan

Employees

398

Website

pbf.com.tw

Financials (FY)

Revenue: $65M
EBITDA: $14M

EV

$172M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Panion & Bf Biotech Financials

Panion & Bf Biotech reported last fiscal year revenue of $65M and EBITDA of $14M.

In the same fiscal year, Panion & Bf Biotech generated $35M in gross profit, $14M in EBITDA, and $6M in net income.

Revenue (LTM)


Panion & Bf Biotech P&L

In the most recent fiscal year, Panion & Bf Biotech reported revenue of $65M and EBITDA of $14M.

Panion & Bf Biotech is profitable as of last fiscal year, with gross margin of 54%, EBITDA margin of 22%, and net margin of 9%.

See analyst estimates for Panion & Bf Biotech
Last FY202320242025202620272028
Revenue$65M$60M$64M$65M
Gross Profit$35M$31M$34M$35M
Gross Margin54%52%53%54%
EBITDA$14M$11M$13M$14M
EBITDA Margin22%19%20%22%
EBIT Margin15%8%11%15%
Net Profit$6M$2M$4M$6M
Net Margin9%4%6%9%
Net Debt$4M---

Financial data powered by Morningstar, Inc.

Panion & Bf Biotech Stock Performance

Panion & Bf Biotech has current market cap of $167M, and enterprise value of $172M.

Market Cap Evolution


Panion & Bf Biotech's stock price is $1.94.

Panion & Bf Biotech share price increased by 1.2% in the last 30 days, and decreased by 14.3% in the last year.

Panion & Bf Biotech has an EPS (earnings per share) of $0.07.

See more trading valuation data for Panion & Bf Biotech
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$172M$167M1.2%1.2%-1.4%-14.3%$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Panion & Bf Biotech Valuation Multiples

Panion & Bf Biotech trades at 2.6x EV/Revenue multiple, and 12.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Panion & Bf Biotech

EV / Revenue (LTM)


Panion & Bf Biotech Financial Valuation Multiples

As of June 5, 2026, Panion & Bf Biotech has market cap of $167M and EV of $172M.

Panion & Bf Biotech has a P/E ratio of 27.6x.

Last FY202320242025202620272028
EV/Revenue2.6x2.9x2.7x2.6x
EV/EBITDA12.2x15.5x13.7x12.2x
EV/EBIT17.6x34.9x25.3x17.6x
EV/Gross Profit4.9x5.6x5.1x4.9x
P/E27.6x68.0x42.1x27.6x
EV/FCF35.9xn/m32.8x35.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Panion & Bf Biotech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Panion & Bf Biotech Margins & Growth Rates

In the most recent fiscal year, Panion & Bf Biotech reported gross margin of 54%, EBITDA margin of 22%, and net margin of 9%.

See estimated margins and future growth rates for Panion & Bf Biotech

Panion & Bf Biotech Margins

Last FY20242025202720282029
Gross Margin54%53%54%
EBITDA Margin22%20%22%
EBIT Margin15%11%15%
Net Margin9%6%9%
FCF Margin7%8%7%

Panion & Bf Biotech Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth8%2%
Gross Profit Growth10%4%
EBITDA Growth13%13%
EBIT Growth38%43%
Net Profit Growth61%53%
FCF Growth(4440%)(9%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Panion & Bf Biotech Operational KPIs

Panion & Bf Biotech's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Panion & Bf Biotech
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.1M---
S&M Expenses to Revenue21%23%22%21%
G&A Expenses to Revenue9%9%8%9%
R&D Expenses to Revenue9%12%12%9%
Opex to Revenue39%44%42%39%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Panion & Bf Biotech Competitors

Panion & Bf Biotech competitors include Precision BioSciences, Innate Pharma, ADC Therapeutics, Hyloris Pharmaceuticals, Acumen Pharmaceuticals, Tenaya Therapeutics, Karolinska Development, NRX Pharmaceuticals, Cereno Scientific and Protalix.

Most Panion & Bf Biotech public comparables operate across Biopharmaceuticals, BioTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Precision BioSciences2.1x2.5x(1.7x)(1.3x)
Innate Pharma14.8x7.2x(4.7x)4.9x
ADC Therapeutics0.7x0.7x(0.6x)-
Hyloris Pharmaceuticals12.8x7.7x(22.0x)(11.2x)
Acumen Pharmaceuticals--(0.6x)(0.6x)
Tenaya Therapeutics-22.3x(1.2x)(1.1x)
Karolinska Development----
NRX Pharmaceuticals134.1x17.2x(10.1x)(10.5x)

This data is available for Pro users. Sign up to see all Panion & Bf Biotech competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Panion & Bf Biotech

When was Panion & Bf Biotech founded?Panion & Bf Biotech was founded in 1976.
Where is Panion & Bf Biotech headquartered?Panion & Bf Biotech is headquartered in Taiwan.
How many employees does Panion & Bf Biotech have?As of today, Panion & Bf Biotech has over 398 employees.
Is Panion & Bf Biotech publicly listed?Yes, Panion & Bf Biotech is a public company listed on Taiwan Stock Exchange.
What is the stock symbol of Panion & Bf Biotech?Panion & Bf Biotech trades under 1760 ticker.
When did Panion & Bf Biotech go public?Panion & Bf Biotech went public in 2004.
Who are competitors of Panion & Bf Biotech?Panion & Bf Biotech main competitors include Precision BioSciences, Innate Pharma, ADC Therapeutics, Hyloris Pharmaceuticals, Acumen Pharmaceuticals, Tenaya Therapeutics, Karolinska Development, NRX Pharmaceuticals, Cereno Scientific, Protalix.
What is the current market cap of Panion & Bf Biotech?Panion & Bf Biotech's current market cap is $167M.
What is the current revenue of Panion & Bf Biotech?Panion & Bf Biotech's last fiscal year revenue is $65M.
What is the current EV/Revenue multiple of Panion & Bf Biotech?Current revenue multiple of Panion & Bf Biotech is 2.6x.
Is Panion & Bf Biotech profitable?No, Panion & Bf Biotech is not profitable.
How many companies Panion & Bf Biotech has acquired to date?Panion & Bf Biotech hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Panion & Bf Biotech has invested to date?Panion & Bf Biotech hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Panion & Bf Biotech

Lists including Panion & Bf Biotech

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial